Acyl
Bluelighter
- Joined
- Apr 13, 2007
- Messages
- 234
Yeah, I was talking about the NH-C(=O)CH3, im not so sure at the ease of which it can be removed in the body.. I suggested it because it seems to happen to tylenol and melatonin if I remember correctly. If a problem with de-acetylation arises it could always just be transformed into NH-C(=O)C[EWD] where EWD stands for an electron withdrawing group that allows for the structure to be cleaved into the PEA derivative and a benign carboxylic acid.
From a chemists stand point (ok well, student of chemistry) that NH-O- bond appears to be very susceptible to acid hydrolysis, mainly in the stomach.
Oh ok, I see where you're coming from now. Ideally, it could work.. But Ive got a feeling that its beyond our abilities. It would be like separating pain killing from the positively reinforcing feelings brought on by opiates. Many organic functions are just too biologically intertwined to be separated. If it did happen, I could see some sort of peptide doing the trick. But then again, I dont really know what Im talking about.. better see a professional about this, this is a pretty cool idea.
I just read a paper about oximes replacing regular amines with affinities to 5-HT receptors.
Turns out, the oxime wouldnt even act as a prodrug. It would complete its deed with its structure more or less intact. Its very possible that the oxime you suggested has similar properties to MDMA, I cant say.. but this paper im looking at didnt substitute the oxime in for an amine in the original structure. Its odd, they removed (theoretically) two carbon atoms, replaced one with an oxygen doubly bonded to a carbon that preceeds (R-C(=O)) it and the other with an alkoxyamine (R2-O-NH2) and formed the oxime by combining the two.
So they busted a part of the original drug molecule, R-CH2-R2 (where R,R2= primary alkyl) into R-C(=O) and H2N-O-R2 and recombined them to give R-C=N-O-R2 .
A major effect of this replacement was a complete loss of reactivity to alpha-andrenergic receptors while still retaining 5-HT1/2 affinities.
source:
itle: Synthesis and 5-HT2A, 5-HT1A and α1- binding affinities of 2-[2-hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl- piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes
Source: Archiv der Pharmazie [0365-6233] Orlandini yr:2007 vol:340 iss:3 pg:135 -139
From a chemists stand point (ok well, student of chemistry) that NH-O- bond appears to be very susceptible to acid hydrolysis, mainly in the stomach.
Acyl: Well no what I was envisaging wouldn't really be satisfied by many existing compounds. More advanced materials are required.
Oh ok, I see where you're coming from now. Ideally, it could work.. But Ive got a feeling that its beyond our abilities. It would be like separating pain killing from the positively reinforcing feelings brought on by opiates. Many organic functions are just too biologically intertwined to be separated. If it did happen, I could see some sort of peptide doing the trick. But then again, I dont really know what Im talking about.. better see a professional about this, this is a pretty cool idea.
I just read a paper about oximes replacing regular amines with affinities to 5-HT receptors.
Turns out, the oxime wouldnt even act as a prodrug. It would complete its deed with its structure more or less intact. Its very possible that the oxime you suggested has similar properties to MDMA, I cant say.. but this paper im looking at didnt substitute the oxime in for an amine in the original structure. Its odd, they removed (theoretically) two carbon atoms, replaced one with an oxygen doubly bonded to a carbon that preceeds (R-C(=O)) it and the other with an alkoxyamine (R2-O-NH2) and formed the oxime by combining the two.
So they busted a part of the original drug molecule, R-CH2-R2 (where R,R2= primary alkyl) into R-C(=O) and H2N-O-R2 and recombined them to give R-C=N-O-R2 .
A major effect of this replacement was a complete loss of reactivity to alpha-andrenergic receptors while still retaining 5-HT1/2 affinities.
source:
itle: Synthesis and 5-HT2A, 5-HT1A and α1- binding affinities of 2-[2-hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl- piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes
Source: Archiv der Pharmazie [0365-6233] Orlandini yr:2007 vol:340 iss:3 pg:135 -139
Last edited:

.